Skip to Content

DA-034 30 (Abilify MyCite 30 mg)

Generic Name: aripiprazole

Pill with imprint DA-034 30 is Pink, Round and has been identified as Abilify MyCite 30 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd.

Abilify MyCite is used in the treatment of bipolar disorder; depression; schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Abilify MyCite 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DA-034 30

Abilify mycite 30 mg DA-034 30

Abilify MyCite

Generic Name
aripiprazole
Imprint
DA-034 30
Strength
30 mg
Color
Pink
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Otsuka Pharmaceutical Co., Ltd
National Drug Code (NDC)
59148-0034
Inactive Ingredients
corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, ferric oxide yellow, ferric oxide red, FD&C Blue No. 2, aluminum oxide, aluminum, magnesium, silicon, silicon dioxide, titanium, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.